C. Foster

发表

Development of a 384-well colorimetric assay to quantify hydrogen peroxide generated by the redox cycling of compounds in the presence of reducing agents.

Peter Wipf, Paul A Johnston, Tong Ying Shun, 2008, Assay and drug development technologies.

Synthesis and Biological Activity of a Focused Library of Mitogen‐activated Protein Kinase Phosphatase Inhibitors

Peter Wipf, Paul A Johnston, Donna M Huryn, 2007, Chemical biology & drug design.

Independent Mechanistic Inhibition of Cdc25 Phosphatases by a Natural Product Caulibugulone

P. Wipf, J. Lazo, R. Tomko, 2007, Molecular Pharmacology.

Independent Mechanistic Inhibition of Cdc 25 Phosphatases by a Natural Product

P. Wipf, J. Lazo, R. Tomko, 2006 .

Halenaquinone and xestoquinone derivatives, inhibitors of Cdc25B phosphatase from a Xestospongia sp.

J. Lazo, D. Kingston, M. Brisson, 2005, Bioorganic & medicinal chemistry.

Sesterterpenoids and an alkaloid from a Thorectandra sp. as inhibitors of the phosphatase Cdc25B.

J. Lazo, D. Kingston, S. Cao, 2005, Bioorganic & medicinal chemistry.

Chemical library screens targeting an HIV-1 accessory factor/host cell kinase complex identify novel antiretroviral compounds.

J. Lazo, T. Smithgall, B. Day, 2009, ACS chemical biology.

Four diterpenoid inhibitors of Cdc25B phosphatase from a marine anemone.

J. Lazo, D. Kingston, S. Cao, 2005, Bioorganic & medicinal chemistry.

Bioactivities of simplified adociaquinone B and naphthoquinone derivatives against Cdc25B, MKP-1, and MKP-3 phosphatases.

J. Lazo, D. Kingston, S. Cao, 2009, Bioorganic & medicinal chemistry.

Redox Regulation of Cdc25B by Cell-Active Quinolinediones

Peter Wipf, Billy W Day, John S Lazo, 2005, Molecular Pharmacology.

Halenaquinone and xestoquinone derivatives, inhibitors of Cdc25B phosphatase from a Xestospongia sp.

J. Lazo, D. Kingston, M. Brisson, 2005, Bioorganic & medicinal chemistry.

Sesterterpenoids and an alkaloid from a Thorectandra sp. as inhibitors of the phosphatase Cdc25B.

J. Lazo, D. Kingston, S. Cao, 2005, Bioorganic & medicinal chemistry.

Development and implementation of a 384-well homogeneous fluorescence intensity high-throughput screening assay to identify mitogen-activated protein kinase phosphatase-1 dual-specificity protein phosphatase inhibitors.

P. Wipf, J. Lazo, P. Johnston, 2007, Assay and drug development technologies.

Development and optimization of high-throughput in vitro protein phosphatase screening assays

J. Lazo, P. Johnston, Sunita Shinde, 2007, Nature Protocols.

Cdc25B dual-specificity phosphatase inhibitors identified in a high-throughput screen of the NIH compound library.

P. Wipf, J. Lazo, P. Johnston, 2009, Assay and drug development technologies.